Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

373
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
373
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

326
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
326
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.1K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.1K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

613
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
613
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

748
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
748
Vaccinations01:51

Vaccinations

50.5K
Overview
50.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intradermal versus subcutaneous immunization: Effects of administration route using a lipid-PLGA hybrid nanoparticle tuberculosis vaccine.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2024
Same author

Cationic pH-sensitive liposomes as tuberculosis subunit vaccine delivery systems: Effect of liposome composition on cellular innate immune responses.

International immunopharmacology·2024
Same author

Cationic pH-sensitive liposome-based subunit tuberculosis vaccine induces protection in mice challenged with Mycobacterium tuberculosis.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2024
Same author

Intrinsic immunogenicity of liposomes for tuberculosis vaccines: Effect of cationic lipid and cholesterol.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2024
Same author

Inflammatory responses in SARS-CoV-2 associated Multisystem Inflammatory Syndrome and Kawasaki Disease in children: An observational study.

PloS one·2022
Same author

Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections.

Scientific reports·2021

Related Experiment Video

Updated: Dec 8, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.8K

[Better vaccines against tuberculosis].

T H M Ottenhoff1,2

  • 1Leids Universitair Medisch Centrum, afd. Infectieziekten, Leiden.

Nederlands Tijdschrift Voor Geneeskunde
|September 17, 2020
PubMed
Summary

Recent breakthroughs in tuberculosis vaccine research offer hope for new, life-saving vaccines. These advancements are crucial for controlling the tuberculosis pandemic and combating drug resistance.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Tuberculosis (TB) remains a global health crisis, necessitating novel control strategies.
  • Increasing multidrug resistance in Mycobacterium tuberculosis complicates treatment and highlights the need for new vaccines.
  • The World Health Organization's End TB Strategy emphasizes the importance of vaccines, drugs, and diagnostics.

Purpose of the Study:

  • To highlight recent significant breakthroughs in tuberculosis vaccine research.
  • To underscore the urgent need for effective tuberculosis vaccines.
  • To emphasize the role of vaccines in the global strategy to end tuberculosis.

Main Methods:

  • Review of recent scientific literature on tuberculosis vaccine development.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.4K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K

Related Experiment Videos

Last Updated: Dec 8, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.8K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.4K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K
  • Analysis of research on correlates of immunity against tuberculosis.
  • Assessment of the impact of these findings on the WHO End TB Strategy.

    • Main Results:

    • Significant research breakthroughs in new tuberculosis vaccines have occurred in the past two years.
    • Correlates of immunity against tuberculosis have been identified, aiding vaccine evaluation.
    • These advancements provide realistic hope for developing and deploying effective TB vaccines.

    Conclusions:

    • New tuberculosis vaccines are critically needed to combat the ongoing pandemic and rising drug resistance.
    • Recent scientific progress offers a promising outlook for the development of effective TB vaccines.
    • Vaccines are a cornerstone of the global effort to control and eventually eliminate tuberculosis.